# Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)

> **NCT06551909** · NA · RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 30 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **RADIATION:** Neoaddjuvant Stereotactic Radiotherapy with Simultaneous Integrated Boost

## Key facts

- **NCT ID:** NCT06551909
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-31
- **Primary completion:** 2026-08-31
- **Final completion:** 2027-02-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-06-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06551909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06551909, "Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06551909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*